New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma-Reference-Cited by-同舟云学术

New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma

Published:2016-07-01 Issue:2 Volume:78 Page:419-426
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Teuma Cécile^ORCID,Perier-Muzet Marie,Pelletier Solenne,Nouvier Mathilde,Amini-Adl Mona,Dijoud Frédérique,Duru Gérard,Thomas Luc,Fouque Denis,Laville Maurice,Dalle Stéphane

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-016-3086-7.pdf

Reference23 articles.

1. Balch CM, Gershenwald JE, Soong S et al (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27(36):6199–6206

2. Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949–954

3. Chapman PB, Hauschild A, Robert C et al (2011) Improved survival with Vemurafenib in Melanoma with BRAF V600E Mutation. N Engl J Med 364(26):2507–2516

4. Sosman JA, Kim KB, Schuchter L et al (2012) Survival in BRAF V600–mutant advanced melanoma treated with vemurafenib. N Engl J Med 366(8):707–714

5. Larkin J, Del Vecchio M, Ascierto PA et al (2014) Vemurafenib in patients with BRAFV600 mutated.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Onco-Hypertension in Patients with Kidney Disease;American Journal of Nephrology;2024-03-18

2. Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma;Nephrology Dialysis Transplantation;2024-02-22

3. Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database;Biomedicines;2023-08-20

4. Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-06-29

5. Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed;Journal of Personalized Medicine;2023-05-11